Device for administering an at least two-component substance

• US 20100217231A1
• Filed: 02/18/2010
• Published: 08/26/2010
• Est. Priority Date: 02/20/2009
• Status: Abandoned Application

• Current Assignee: Omrix Biopharmaceuticals Limited (Johnson & Johnson)
• Original Assignee: Omrix Biopharmaceuticals Limited (Johnson & Johnson)
• Inventors: Nur, Israel, Bar, Liliana, Meron, Moti, Regev, Kfir, Ilan, Erez
• Application Number:
  US12/708,453
• Publication Number:
  US 20100217231A1
• Time in Patent Office: Days
• US Class Current: 604/506
• CPC Class Codes: A61B 17/00491 Surgical glue applicators surgical adhesives A61L24/00; two-component delivery syringes A61M5/19
• CPC Class Codes: A61B 2017/00495 for two-component glue
• CPC Class Codes: A61M 2025/0039 characterized by lumina being arranged coaxially
• CPC Class Codes: A61M 5/1582 Double lumen needles
• CPC Class Codes: A61M 5/3297 Needles arranged coaxially
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 7/04 Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Abstract

The device for administering an at least two-component substance comprises a concentric lumen arrangement including (i) an inner cannula having a lumen with an inlet opening at a first end and a tip with an outlet opening at a second end opposite its first end, and (ii) an outer sheath having opposite first and second ends facing the respective first and second ends of the inner cannula, and surrounding the inner cannula along an axial length between the first and second ends of the inner cannula, wherein the outer sheath at its second end is sealingly and fixedly connected to the inner cannula and defining an outer lumen around the inner cannula, and wherein the inner cannula is provided with at least one opening for providing fluid communication between the outer lumen around the inner cannula and the lumen of the inner cannula.

Claims

1. A device for administering an at least two-component substance, comprising

a concentric lumen arrangement including (i) an inner cannula having a lumen with an inlet opening at a first end and a tip with an outlet opening at a second end opposite its first end, and (ii) an outer sheath having opposite first and second ends facing the respective first and second ends of the inner cannula, and surrounding the inner cannula along an axial length between the first and second ends of the inner cannula,

wherein the outer sheath at its second end is sealingly and fixedly connected to the inner cannula and defining an outer lumen around the inner cannula, and

wherein the inner cannula is provided with at least one opening for providing fluid communication between the outer lumen around the inner cannula and the lumen of the inner cannula.

2. The device according to claim 1, further comprising at least a first and a second storage containers for storing the components of the substance, wherein the containers are capable of being connected to the concentric lumen arrangement with the first container in fluid communication with the lumen of the inner cannula and the second container in fluid communication with the outer lumen around the inner cannula.

3. The device according to claim 1, further comprising a connecting element for providing fluid communication between the container and the concentric lumen arrangement.

4. The device according to claim 3, wherein the connecting element comprises a first port for connecting to the first container and a second port for connecting to the second container, wherein the first port is in fluid communication with the inlet opening of the inner cannula and the second port is in fluid communication with the outer lumen at the first end of the outer sheath.

5. The device according to claim 4, wherein the connecting element further comprises a holding element for holding the inner cannula and outer sheath of the concentric lumen arrangement, wherein the holding element comprises an inner hollow space through which the concentric lumen arrangement extends, with the first end of the outer sheath located within the hollow space and the inner cannula further extending through the terminal element, and wherein a connecting channel is provided starting from the second port and terminating in the inner hollow space of the terminal element.

6. The device according to claim 1, wherein the at least one opening of the inner cannula is arranged adjacent the second end of the outer sheath.

7. The device according to claim 1, wherein the concentric lumen arrangement further comprises at least one further sheath surrounding the outer sheath along an axial length thereof and comprising first and second ends facing the first and second ends of the outer sheath, respectively, wherein the further sheath is sealingly connected to the outer sheath adjacent the second end thereof and defining a further lumen around the outer sheath, and wherein the outer sheath is provided with at least a second opening providing fluid communication between the further outer lumen around the outer sheath and the lumen within the outer sheath around the inner cannula, and wherein at least one further storage container is provided for storing a further component of the substance and capable of being connected to the first end of the at least one further sheath of the concentric lumen arrangement.

8. The device according to claim 1, further comprising a pressing mechanism for pressing the components out of the containers to the concentric lumen arrangement and further therethrough out of the tip at the second end of the inner cannula.

9. The device according to claim 1, wherein the at least one component is activated by the at least second component of the substance.

10. The device according to claim 1, wherein the at least one component comprises fibrinogen, and the at least second component comprises thrombin.

11. The device according to claim 1, wherein the administering is carried out by injection.

12. The device according to a claim 1, wherein the administering is carried out by spraying or dripping.

13. A method of administering to a subject in need a substance comprising at least two components, the method comprising the steps of:

providing a device according to claim 1,

piercing the tip of the inner cannula of the concentric lumen arrangement into a biological tissue, and

administering the at least two component substance in a mixed condition through the tip of the inner cannula of the concentric lumen arrangement.

14. The method according to claim 13, wherein the substance is a fibrin sealant with a fibrinogen component and a thrombin component.

15. The method according to claim 13, wherein the substance is a drug with a drug precursor component and a drug precursor activator component.

16. A method of administering to a subject in need a substance comprising at least two components, the method comprising the steps of:

providing a device according to claim 1, and

administering onto a biological tissue the at least two component substance in a mixed condition through the tip of the inner cannula of the concentric lumen arrangement, wherein the step of administering is carried out by dripping or spraying.

17. A method of treating a tissue defect in a subject, comprising the steps of:

providing a device according to claim 1, and

administering a substance comprising at least two components in a mixed condition to the patient.

18. The method according to claim 17, wherein the defect is selected from the group consisting of renal defects;

fistulas;

ulcers;

bleeding;

fissures or cracks in the dura;

cerebrospinal fluid leakage;

spine disease, disorder or condition such as spinal disc defects, full tears and fissures in the annulus fibrosus, punctures in the annulus fibrosus, fissures or cracks in the intervertebral disc or a reduction in the height of the intervertebral discs;

cardiovascular disease;

heart disease;

burn eschars;

seromas such as seromas following mastectomy;

hemorrhoids;

air leaks such as in pulmonary resection;

malignant pleural effusion;

cystitis; and

anastomosis such as ureteral anastomosis or intestinal anastomosis.

19. The method according to claim 17, wherein the substance is a sealant.

20. The method according to claim 19, wherein the sealant is a fibrin sealant.

21. Use of a device according to claim 1 for administering onto a surface a substance comprising at least two components in a mixed condition through the tip of the inner cannula of the concentric lumen arrangement.

22. The use according to claim 21, wherein the administering is carried out by dripping or spraying.

23. The use according to claim 21, wherein the surface is a surface of a body part of a patient.

24. The use according to claim 21, wherein the substance is a fibrin sealant with a fibrinogen component and a thrombin component.

25. The use according to claim 21, wherein the substance is a drug with a drug precursor component and a drug precursor activator component.